Amid its plummeting stock value, layoffs and cuts to its drug R&D program, the battered company is carrying on.

Me, a major company providing direct-to-consumer genetic testing, has been struggling financially since late 2023. In September 2024, the ...

It was a simple process. You’d collect a saliva sample, ship it off, and within six weeks, you’d receive a complete ancestral ...

In the wake of a big data breach and a sizable new round of layoffs, 23andMe's troubles have some people looking to delete ...

A federal judge granted early approval to a $30 million settlement to resolve claims 23andMe Inc. failed to protect the ...

A trio of women accused the streaming giant of disclosing their names without their consent in the documentary.

A jury ordered Netflix to pay $385,000 to a woman who was outed in 'Our Father' as the secret child of notorious fertility ...

Netflix was ordered to pay an Indiana woman $385,000 after a federal court ruled that a documentary about disgraced fertility doctor Donald Cline exposed her as one of his daughters.

23andMe's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and sweeping job losses. The company that made its name by providing saliva ...

Johns Hopkins researchers have developed a powerful new AI tool called "Splam" that can identify where splicing occurs in ...

Now, an alliance between Novartis and genetic testing specialist 23andMe is trying to encourage greater awareness of Lp(a) and improve testing rates. The pilot programme will see a confidential ...